Cloning and the Debate on Abortion
By Nigel Cameron and Lori Andrews,
Chicago Tribune
| 08. 08. 2001
Italian fertility specialist Severino Antinori has announced
that he will begin human cloning in early 2002. Two hundred
couples desperately seeking to create children will become human
guinea pigs in a massive experiment. The odds are not in their
favor. In animals, cloning currently only results in a successful
pregnancy 3 to 5 percent of the time. And, even in those rare
instances, many of the resulting offspring suffer. One-third
die shortly before or right after birth. Other cloned animals
seem perfectly healthy at first and then suffer heart and blood
vessel problems, underdeveloped lungs, diabetes, immune system
deficiencies and severe growth abnormalities.
If an infectious disease were killing one-third of human infants,
we would declare it a public health emergency. We certainly
wouldn’t set up a clinic to enable it to happen. Yet despite
these grave risks, only five states have laws banning human
cloning. There is no federal law on the subject yet. Despite
widespread public opposition to human cloning, various researchers
and biotech companies have so far prevented the passage of such
a law.
This summer, however...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Susanna Smith, Genetic Frontiers | 07.28.2025
Key Topics
How does the American far right view genetics and genetic technologies?
What is the history of the American cultural pursuit of trying to choose smarter children? What has science shown us about the relationship of heredity and intelligence...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...